COVID-19 pandemic
The European Medicines Agency authorizes the usage of the Pfizer–BioNTech COVID-19 vaccine for people aged 12 to 15 years old, becoming the first vaccine to be approved for children in the European Union.
Sources: France 24
Changes
- The European Medicines Agency authorizes the usage of the Pfizer–BioNTech COVID-19 vaccine for people aged 12 to 15, becoming the first vaccine to be approved for children in the European Union.
- The European Medicines Agency authorizes the usage of the Pfizer–BioNTech COVID-19 vaccine for people aged 12 to 15 years old, becoming the first vaccine to be approved for children in the European Union.